K Kloc-Muniak

Affiliations
  • Tecrea Ltd. 2 Royal College Street, London NW1 0NH, United Kingdom.

Publications (1)

CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.

International journal of pharmaceutics
Avec: A Tirella , K Kloc-Muniak , L Good , J Ridden , M Ashford , S Puri , N Tirelli

Réseau de co-auteurs

A Tirella 1 collaboration
L Good 1 collaboration
J Ridden 1 collaboration
M Ashford 1 collaboration
S Puri 1 collaboration
N Tirelli 1 collaboration